US-based Skyhawk Therapeutics has formed a strategic alliance with Takeda Pharmaceutical to discover and develop small molecule drug candidates for multiple targets across neurodegenerative diseases.
7 May 2019 News
24 April 2019 News
Israeli pharmaceutical company Teva has announced the discontinuation of its ENFORCE Phase III trial programme investigating the safety and efficacy of Ajovy (fremanezumab) for episodic cluster headaches.
23 April 2019 pressreleases
Creative Pharma Services attended the Hellenic Society for Pharmaceutical Management on 18 April.
15 April 2019 News
Agroceutical Products, a bioresearch company based in Powys, Wales, is helping thousands of Alzheimer’s patients worldwide by supplying galantamine, a compound derived from daffodils that slows down the progression of...
3 April 2019 Comment
There is a great unmet need for simple, inexpensive, and non-invasive tests that could be applied on a large scale to screen for Alzheimer's disease (AD). Finding a biomarker in...
29 March 2019 Analysis
World Bipolar Day aims to eliminate the social stigma that remains associated with bipolar disorder. This and a deficiency of treatments remain the significant barriers to successful treatment of the...
27 March 2019 News
Swiss Ecole Polytechnique Fédérale de Lausanne (EPFL)’s Blue Brain Project has used a mathematical algorithm to distinguish the shape and structures of pyramidal cells.
22 March 2019 News
Biogen and Eisai have announced they are discontinuing two Phase III trials, Engage and Emerge, evaluating the safety and efficacy of aducanumab in patients with Alzheimer’s disease and mild Alzheimer’s...
13 March 2019 News
The Royal College of Surgeons in Ireland has been awarded a grant for a new research project that seeks to improve scientific understanding of Parkinson’s disease and lead to the...